Diabetes mellitus is a chronic metabolic condition characterized by elevated blood glucose levels, and early diagnosis is essential to prevent longterm complications such as vision loss, kidney failure, heart disease, and nerve damage. Worldwide health authorities, including the World Health Organization (WHO), provide standardized criteria to help clinicians and health services identify people with diabetes so that treatment and preventive care can begin promptly. The latest WHO criteria for diagnosis of diabetes mellitus reflect evidencebased thresholds for blood glucose measures and support global efforts to unify diagnosis standards, improve early detection, and reduce the burden of diabetes on individuals and health systems.
Basic Principles of WHO Diagnostic Criteria
The WHO diagnostic criteria are based on measurements of blood glucose levels taken at specific times and under defined conditions. These criteria identify whether an individual has diabetes mellitus or is at increased risk of developing diabetes (prediabetes). A diagnosis should be confirmed with repeat testing or through multiple abnormal test results to ensure accuracy. WHO emphasizes that measurements must be performed in properly calibrated laboratories and interpreted according to defined thresholds.
Important Terms in Diagnosis
- Fasting Plasma Glucose (FPG)Blood sugar measured after at least eight hours without eating.
- Postload GlucoseBlood sugar measured two hours after a 75gram oral glucose tolerance test (OGTT).
- Random Plasma GlucoseBlood sugar measured at any time of the day, especially in people with symptoms.
- Glycated Hemoglobin (HbA1c)Reflects average blood glucose levels over approximately three months and is used as an additional diagnostic option.
WHO Criteria for Diagnosing Diabetes Mellitus
According to the most recent WHO criteria for diagnosing diabetes mellitus, an individual meets the diagnostic threshold if one of the following conditions is fulfilled and confirmed with a repeat test, unless there are clear symptoms and a high glucose level.
Fasting Plasma Glucose (FPG)
A fasting plasma glucose level of 7.0 mmol/L (126 mg/dL) or greater is considered diagnostic for diabetes. Fasting means no caloric intake for at least eight hours before the test. Elevated FPG indicates that the body is not effectively regulating blood glucose after a period without food.
TwoHour Plasma Glucose After OGTT
The oral glucose tolerance test (OGTT) involves measuring blood glucose two hours after consuming a 75gram glucose drink. A result of 11.1 mmol/L (200 mg/dL) or higher two hours after the glucose load is diagnostic for diabetes. This test is useful when fasting glucose results are borderline but clinical suspicion remains high.
HbA1c Level
WHO recommends an HbA1c value of 6.5% (48 mmol/mol) or higher as a diagnostic criterion for diabetes, provided that the measurement is performed with a standardized and qualityassured method. HbA1c testing does not require fasting and reflects average glycemia over prior months, making it useful for both screening and diagnosis.
Random Plasma Glucose in Symptomatic Individuals
A random plasma glucose concentration of 11.1 mmol/L (200 mg/dL) or higher in someone with classic symptoms of hyperglycemia-such as increased thirst, frequent urination, unexplained weight loss, or fatigue-is sufficient for diagnosis even without fasting or postload testing.
Intermediate Hyperglycemia PreDiabetes Conditions
While the main focus is on the diagnosis of diabetes, the WHO also recognizes categories of intermediate hyperglycemia. These categories help identify individuals at high risk for developing diabetes so that preventive measures can be implemented.
Impaired Fasting Glycaemia (IFG)
Impaired fasting glycaemia is defined as a fasting plasma glucose between 6.1 mmol/L and 6.9 mmol/L (110-125 mg/dL). Individuals within this range do not meet the criteria for diabetes but are at increased risk of progression to diabetes and cardiovascular disease.
Impaired Glucose Tolerance (IGT)
Impaired glucose tolerance is identified when the twohour plasma glucose after an OGTT is between 7.8 mmol/L and 11.0 mmol/L (140-199 mg/dL). IGT also represents a highrisk state and is often used in diabetes prevention strategies.
Confirmatory Testing and Quality Assurance
A diagnosis should never be based on a single abnormal glucose value in the absence of symptoms. WHO guidelines recommend confirmatory testing, meaning that either a second abnormal result on a separate day is required or a second type of test (for example, FPG and HbA1c) shows concordant findings. This approach reduces the risk of misdiagnosis due to laboratory variability or transient changes in glucose levels.
Role of Laboratory Standards
Accurate diagnosis relies on standardized testing methods and quality control in laboratories. For HbA1c, WHO specifies that the assay should be certified and traceable to international reference standards to ensure reliable comparisons across settings. Use of nonstandardized methods may lead to inconsistent results and misclassification.
Diagnosis in Special Populations
Some populations require specific considerations. For example, certain ethnic groups may have different risk profiles, and pregnancy involves different diagnostic thresholds to identify gestational diabetes. While WHO criteria for gestational diabetes mellitus are based on separate recommendations, the general principles of confirming elevated glucose values remain similar.
Gestational Diabetes Mellitus (GDM)
Although WHO has separate recommendations for GDM, the principles of diagnosing diabetes with elevated glucose values apply. For pregnancy, diagnostic thresholds may involve fasting glucose values and OGTT results at specific time points designed to identify risk for both mother and baby. These criteria aim to reduce adverse outcomes associated with elevated blood glucose during pregnancy.
Importance of Early Diagnosis and Intervention
Early detection of diabetes allows for timely intervention to prevent or delay complications. Once diagnosed, individuals can receive education about lifestyle changes, blood glucose monitoring, and appropriate medication when needed. WHO underscores that untreated diabetes can lead to serious complications affecting the heart, kidneys, eyes, and nerves. Regular screening of highrisk individuals, such as those with obesity, family history, or older age, can improve outcomes.
Public Health Implications
At a population level, standardized diagnostic criteria help countries monitor the prevalence of diabetes, plan health services, and allocate resources for prevention and management programs. Consistency in diagnosis also allows for comparison of data across regions and time, assisting global efforts to reduce the burden of this chronic disease.
The latest WHO criteria for diagnosis of diabetes mellitus provide clear, evidencebased thresholds based on fasting plasma glucose, oral glucose tolerance testing, HbA1c levels, and random glucose measurements in symptomatic individuals. These criteria help clinicians accurately identify diabetes and prediabetes, supporting early intervention and improved longterm outcomes. Confirmation of abnormal results through repeat testing and adherence to laboratory standards are key to reliable diagnosis. By identifying elevated glucose levels early, individuals and health systems can take steps to prevent complications, enhance quality of life, and reduce the global burden of diabetes.